Karen Hong
Partner at De Novo Ventures
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
About
Karen Hong is a Boston-based co-founder of Cold Spring Bio LLC with experience as a venture and public market biopharmaceutical investor. She serves as a board member focused on healthcare company formation and development.
Experience
- Cold Spring Bio LLCCo-Foundercurrent2024 — presentNewton, Massachusetts, United States
- Novo VenturesPartner2019 — 2024Boston, Massachusetts, United States
- Cyteir TherapeuticsBoard Member2019 — 2021Lexington, Massachusetts, United States
- TakedaSenior Investment Director, Takeda Ventures, Inc.2017 — 2019Greater Boston
- Clarus TherapeuticsBoard Director2011 — 2016Northbrook, IL
- Agile TherapeuticsBoard Director2006 — 2016Princeton, NJ
- ProQuest InvestmentsPartner2001 — 2016Princeton, NJ
- Gloucester PharmaceuticalsBoard Observer2004 — 2010Cambridge, MA
Education
- Massachusetts Institute of TechnologyPh.D., Molecular Biology1993 — 2001
- University of California, BerkeleyBachelor's Degree, B.S. Chemistry and B.A. Molecular Biology1989 — 1993
Skills & more
Valuation3Private Equity13Pharmaceutical Industry11Commercialization7Mergers & Acquisitions17Due Diligence1Hedge Funds1Business Strategy3Strategy6Medical Devices3Start-ups4Entrepreneurship2
+8 more
Corporate DevelopmentInvestment BankingVenture FinancingInvestmentsFinancial ModelingBusiness DevelopmentStrategic PlanningTechnology TransferLanguages English · French · Mandarin Chinese
From Karen's professional profile.